Former U.S. President Joe Biden’s recent cancer diagnosis brought widespread attention to what is known as the “Gleason score,” a grading system used to assess the prognosis of men with prostate cancer. In the latest “Rose Walk and Talk” video, Dr. Michael Leapman, a Yale urologist and clinical program leader for the Prostate & Urologic Cancers Program at Yale Cancer Center, explains how the score works and how it helps doctors establish a customized treatment plan for patients.
What is the Gleason Score and how does it affect prostate cancer treatment?
In the latest “Rose Walk and Talk,” Yale urologist Michael Leapman explains how the “Gleason score” helps doctors assess the prognosis of men with prostate cancer — and craft customized treatment plans.
1 min read
